Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging
The discussion covers why engineered GLP-1 drugs achieve robust brain effects on satiety and food preference that endogenous GLP-1 does not, along with her teams genomic approach to discovering additional peptides that act on distinct brain pathways
Theyll do a hearing test, examine your head and neck, and look inside your ears
Consider additional metrics such as waist circumference, how clothing fits, and improvements in blood glucose control and overall wellbeing
Now, first off, I love this study because it validates what I've been doing for the past 15 years
The psychological experience matters as much as the physical changes